Minimum biopsy set for HER2 evaluation in gastric and gastro-esophageal junction cancer
Background and study aims: The HER2 status of small endoscopic biopsies is important for predicting the eligibility of patients with metastatic HER2-positive gastric cancer or gastro-esophageal junction (GEJ) cancer for anti-HER2 therapy approved by the U.S. Food and Drug Administration. The aim of...
Main Authors: | Irene Gullo, Federica Grillo, Luca Molinaro, Matteo Fassan, Annalisa De Silvestri, Carmine Tinelli, Massimo Rugge, Roberto Fiocca, Luca Mastracci |
---|---|
Format: | Article |
Language: | English |
Published: |
Georg Thieme Verlag KG
2015-02-01
|
Series: | Endoscopy International Open |
Online Access: | http://www.thieme-connect.de/DOI/DOI?10.1055/s-0034-1391359 |
Similar Items
-
The Reliability of Endoscopic Biopsies in Assessing HER2 Status in Gastric and Gastroesophageal Junction Cancer: A Study Comparing Biopsies with Surgical Samples
by: Federica Grillo, et al.
Published: (2013-02-01) -
HER 2 Expression in Gastric and Gastro-esophageal Junction (GEJ) Adenocarcinomas
by: Indu Rajagopal, et al.
Published: (2015-03-01) -
Scalp Metastasis of Gastro-Esophageal Junction Adenocarcinoma: A Rare Occurrence
by: Asitava Deb Roy, et al.
Published: (2014-02-01) -
Characterization of Primary Esophageal/Gastro-esophageal Junction Cancer Xenograft Models and their Effectiveness in Studying Chemosensitivity
by: Dodbiba, Lorin
Published: (2013) -
Characterization of Primary Esophageal/Gastro-esophageal Junction Cancer Xenograft Models and their Effectiveness in Studying Chemosensitivity
by: Dodbiba, Lorin
Published: (2013)